In the first quarter of 2026, the FDA issued nine approvals in oncology, including treatments for blood cancers, pancreatic...
As part of ongoing efforts to increase dialogue between cancer patients, survivors, physicians, and researchers, Cancer Today hosts an...
In the midst of the dog days of summer, the U.S. Food and Drug Administration (FDA) has provided good...
Treatment with checkpoint inhibitors is often billed as gentler than chemotherapy—and it is true that immunotherapy doesn’t come with...
Biopsies have been an integral part of cancer care for decades. In undiagnosed patients, oncologists can examine suspicious tissues...
Last year, the U.S. Food and Drug Administration approved 15 new anticancer therapeutics. More groundbreaking treatments are on the...
During the early part of summer 2018, the U.S. Food and Drug Administration (FDA) has approved several new anticancer...
Each month, the American Association for Cancer Research (AACR) publishes 10 articles from its eight esteemed scientific journals, showcasing...
Policymakers, parents, teachers, and public health professionals have all expressed concern about the rise in teen vaping and a...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today Do cancer cells have Achilles’ heels? The answer...
This week marks the fourth anniversary of Cancer Research Catalyst, the official blog of the American Association for Cancer...